| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |